Mirae Asset Global ETFs Holdings
ROIV icon

Mirae Asset Global ETFs Holdings’s Roivant Sciences ROIV Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Buy
11,287
+482
+4% +$14.2K ﹤0.01% 2128
2026
Q1 		$285K Sell
10,805
-6,032
-36% -$155K ﹤0.01% 2175
2025
Q4 		$364K Sell
16,837
-7,116
-30% -$140K ﹤0.01% 2048
2025
Q3 		$362K Sell
23,953
-4,909
-17% -$60.8K ﹤0.01% 2027
2025
Q2 		$329K Buy
28,862
+5,782
+25% +$62.7K ﹤0.01% 2022
2025
Q1 		$240K Sell
23,080
-5,294
-19% -$57.2K ﹤0.01% 2236
2024
Q4 		$324K Sell
28,374
-55,508
-66% -$656K ﹤0.01% 2127
2024
Q3 		$966K Sell
83,882
-7,562
-8% -$86.1K ﹤0.01% 1559
2024
Q2 		$967K Buy
+91,444
New +$1M ﹤0.01% 1472

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ROIV Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Roivant Sciences (ROIV) stake by 4.5% in Q2 2026, buying an estimated $14.2K and bringing the position to 11,287 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #2128.

Mirae Asset Global ETFs Holdings first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. The position peaked at $967K in Q2 2024. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 11,287 shares of Roivant Sciences worth $392K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 482 Roivant Sciences shares in Q2 2026, an estimated $14.2K.
  • Roivant Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2128 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Roivant Sciences position peaked at $967K in Q2 2024.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.